Health Trials

About this trial

Study of the osteoconductive potential of the injectable bone substitute In'Oss™ (MBCP® Putty) in the filling of orthopaedic bone defects to collect Post-Market Clinical Follow-up (PMCF) data for the CE-marked In'Oss™ (MBCP® Putty) device in the orthopaedic trauma surgery

Eligibility criteria

Qualifiers

Patient is male or female, 18 - 85 years old;

Patient is willing and able to give written informed consent;

Patient is able to comply with a prior medical examination;

Proximal humerus ▪ Distal radius

Disqualifiers

Patient has had an infection in the same extremity within last 24 months;

Patient has signs of necrosis at the surgical site;

Patient has cellulitis;

Patient has granuloma or non-curetted cyst;

Trial design

Treatments tested in this trial

  • In'Oss™ (MBCP® Putty)

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Advanced Medical Solutions Ltd.

Lead sponsor

Source ClinicalTrials.gov